Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Neuropharmacology. 2012 Mar 23;63(2):190–201. doi: 10.1016/j.neuropharm.2012.03.014

Table 1.

Three doses of IVM were evaluated to determine the IVM disposition in both plasma and brain tissue. IVM produced a dose-dependent increase in detectable IVM levels in plasma and brain tissue.

IVM Dose (mg/kg) % Reduction of Ethanol Consumption IVM Plasma AUC0-8 (ng*hr/mL) IVM Brain AUC (ng*hr/mg)
0.25 No Effect 48.91 9.6×10−05
2.5 32 % 155.56 2.8×10−01
10 > 50% 2928.31 2.20×1000